Percutaneous coronary intervention (PCI) of chronic total occlusions (CTOs) is increasingly being performed in patients with advanced coronary artery disease, but there is limited information on the techniques utilized and the procedural outcomes. The goal of this multicenter, investigator initiated registry is to collect information on treatment strategies and outcomes of consecutive patients undergoing CTO PCI among various participating centers. The information collected will be used to determine the frequency of CTO PCI performed at the participating sites and examine the procedural strategies utilized, and the procedural (both immediate and during follow-up) outcomes.
Study Type
OBSERVATIONAL
Enrollment
2,000
Banner Samaritan Health Center
Phoenix, Arizona, United States
COMPLETEDLittle Rock VA Medical Center
Little Rock, Arkansas, United States
RECRUITINGSan Diego VAMC and University of California
San Diego, California, United States
RECRUITINGTorrance Memorial Medical Center
Torrance, California, United States
ACTIVE_NOT_RECRUITINGMedical Center of the Rockies
Loveland, Colorado, United States
RECRUITINGMemorial Hospital
Jacksonville, Florida, United States
RECRUITINGPiedmont Heart Institute
Atlanta, Georgia, United States
ACTIVE_NOT_RECRUITINGEmory University Hospital- Emory Heart and Vascular Center
Atlanta, Georgia, United States
RECRUITINGWellstar Health System
Marietta, Georgia, United States
RECRUITINGNorthwestern Bluhm Cardiovascular Institute
Chicago, Illinois, United States
ACTIVE_NOT_RECRUITING...and 38 more locations
procedural success of chronic total occlusion PCI
Procedural success is defined as achievement of technical success with no in-hospital major adverse cardiac events (MACE). In-hospital MACE includes any of the following adverse events prior to hospital discharge: death from any cause, Q-wave myocardial infarction, urgent repeat target vessel revascularization with PCI or coronary bypass surgery, tamponade requiring pericardiocentesis or surgery, or stroke.
Time frame: discharge from the hospital after PCI, which usually happens the day after the procedure
technical success of chronic total occlusion PCI
Technical success of CTO PCI was defined as successful CTO revascularization with achievement of \<30% residual diameter stenosis within the treated segment and restoration of TIMI grade 3 antegrade flow.
Time frame: discharge from the hospital after PCI, which usually happens the day after the procedure
major adverse cardiovascular events
In-hospital major adverse cardiovascular events (MACE) include any of the following adverse events prior to hospital discharge: death from any cause, Q-wave myocardial infarction, urgent repeat target vessel revascularization with PCI or coronary bypass surgery, tamponade requiring pericardiocentesis or surgery, or stroke. MACE during clinical follow-up include death, myocardial infarction, target lesion and target vessel revascularization.
Time frame: discharge from the hospital after PCI (which usually happens the day after the procedure) and during clinically-indicated follow-up. There are no pre-specified follow-up time periods - patients are assessed if and when they come to receive clinical care.
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.